Experimental Drug Shows Promise for Rare Genetic Disorder
New therapy may combat amyloidosis, the potentially deadly disease caused by protein build-up in organs (Source: WebMD Health)
Source: WebMD Health - August 29, 2013 Category: Consumer Health News Source Type: news
Novel Approach to Amyloidosis Looks Promising (CME/CE)
(MedPage Today) -- An amyloidosis therapeutic strategy based on controlling gene expression passed a proof-of-concept test, suppressing transthyretin production in patients with transthyretin amyloidosis, investigators reported. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - August 29, 2013 Category: Cardiology Source Type: news
Experimental Drug Shows Promise for Rare Genetic Disorder
New therapy may combat amyloidosis, the potentially deadly disease caused by protein build-up in organs
Source: HealthDay
Related MedlinePlus Page: Amyloidosis (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - August 29, 2013 Category: Consumer Health News Source Type: news
Dreaming of animals and other warning signs of neurodegeneration | Mo Costandi
Sleep disturbances may be an early warning sign of Alzheimer's and other neurodegenerative diseasesThe latest issue of Nature contains an Outlook supplement about the health impacts of poor sleep, including a feature I wrote about the link between sleep disturbances and neurodegenerative diseases, called "Amyloid awakenings". The title refers to a process called amyloidosis, by which mutated, abnormally folded proteins aggregate to form insoluble clumps in the brain. Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - May 22, 2013 Category: Science Authors: Mo Costandi Tags: Neuroscience Sleep Health & wellbeing Alzheimer's Society Source Type: news
Prothena doses first patient in Phase I study of NEOD001
Clinical stage biotechnology company Prothena has dosed the first AL amyloidosis patient in its Phase I study of NEOD001, an antibody therapeutic candidate. (Source: Drug Development Technology)
Source: Drug Development Technology - April 23, 2013 Category: Pharmaceuticals Source Type: news
Detecting Cardiac Amyloidosis Using Amyloid Imaging
While amyloid imaging may now be most associated with detecting plaques in the brain, it has the potential to change the way cardiac amyloidosis is diagnosed. According to first-of-its-kind research published in the February issue of The Journal of Nuclear Medicine, positron emission tomography (PET) with 11C-PIB can positively visualize amyloid deposits in the heart. Currently there is no noninvasive test available for specific diagnosis. Cardiac amyloidosis is a deadly disorder caused by abnormal amyloid deposits in the heart tissue... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 7, 2013 Category: Consumer Health News Tags: Cardiovascular / Cardiology Source Type: news
Amyloid Imaging May Help Detect Cardiac Amyloidosis
Amyloid imaging, used to detect plaques in the brain, may help diagnose cardiac amyloidosis, researchers said. (Source: Diagnostic Imaging)
Source: Diagnostic Imaging - February 5, 2013 Category: Radiology Source Type: news
Amyloid imaging shows promise for detecting cardiac amyloidosis
While amyloid imaging may now be most associated with detecting plaques in the brain, it has the potential to change the way cardiac amyloidosis is diagnosed. According to first-of-its-kind research, positron emission tomography with 11C-PIB can positively visualize amyloid deposits in the heart. Currently there is no noninvasive test available for specific diagnosis. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 4, 2013 Category: Science Source Type: news
Amyloid imaging shows promise for detecting cardiac amyloidosis
(Society of Nuclear Medicine) While amyloid imaging may now be most associated with detecting plaques in the brain, it has the potential to change the way cardiac amyloidosis is diagnosed. According to first-of-its-kind research published in the February issue of The Journal of Nuclear Medicine, positron emission tomography with 11C-PIB can positively visualize amyloid deposits in the heart. Currently there is no noninvasive test available for specific diagnosis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 4, 2013 Category: Global & Universal Source Type: news
